Peak flow variation in childhood asthma: Relationship to symptoms, atopy, airways obstruction and hyperresponsiveness

European Respiratory Journal

Volumn 10, Issue 6, 1997, Pages 1242-1247

  Brand, P L P ^a   Duiverman, E J ^b   Postma, D S ^c   Waalkens, H J ^a   Kerrebijn, K F ^d   Van Essen Zandvliet, E E M ^d  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b JULIANA CHILDREN S HOSPITAL   (Netherlands)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^d SOPHIA CHILDREN S HOSPITAL   (Netherlands)

Author keywords

Asthma; Child; Peak expiratory flow; Peak flow variation

Indexed keywords

HISTAMINE;

ADOLESCENT; AIRWAY OBSTRUCTION; ARTICLE; ASTHMA; ATOPY; BRONCHUS HYPERREACTIVITY; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; PEAK EXPIRATORY FLOW; PRIORITY JOURNAL; SCHOOL CHILD;

ADOLESCENT; ASTHMA; BRONCHIAL HYPERREACTIVITY; BRONCHIAL PROVOCATION TESTS; CHILD; FEMALE; FORCED EXPIRATORY VOLUME; HISTAMINE; HUMANS; HYPERSENSITIVITY, IMMEDIATE; IMMUNOGLOBULIN E; MALE; PEAK EXPIRATORY FLOW RATE; PULMONARY VENTILATION; RADIOALLERGOSORBENT TEST;

EID: 0031008599     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.97.10061242     Document Type: Article

References (23)

1. Joint Task Force on Practice Parameters. Practice parameters for the diagnosis and treatment of asthma. J Allergy Clin Immunol 1995; 96 (Suppl.): 858-870.
2. Anonymous. Asthma: a follow-up statement from an international paediatric asthma consensus group. Arch Dis Child 1992; 67: 240-248.
3. British Thoracic Society and others. Guidelines for the management of asthma: a summary. BMJ 1993; 306: 776-782.
4. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am Rev Respir Dis 1987; 136: 225-244.
5. Clough JB, Williams JD, Holgate ST. Effect of atopy on the natural history of symptoms, peak expiratory flow, and bronchial responsiveness in 7 and 8 year old children with cough and wheeze. Am Rev Respir Dis 1991; 143: 755-760.
6. Gern JE, Eggleston PA, Schuberth KC, et al. Peak flow variation in childhood asthma: a three year analysis. J Allergy Clin Immunol 1994; 93: 706-716.
7. 2-agonists on lung function, airway responsiveness, and symptoms in children with asthma. Am Rev Respir Dis 1992; 146: 547-554.
8. Kerstjens HAM, Brand PLP, de Jong PM, Koëter GH, Postma DS, Dutch CNSLD Study Group. Influence of treatment on peak expiratory flow and its relation to airway hyperresponsiveness and symptoms. Thorax 1994; 49: 1109-1115.
9. Higgins B, Britton JR, Chinn S, et al. The distribution of peak expiratory flow variability in a population sample. Am Rev Respir Dis 1989; 140: 1368-1372.
10. Siersted HC, Hansen HS, Hansen N-CG, Hyldebrandt N, Mostgaard G, Oxhoy H. Evaluation of peak expiratory flow variability in an adolescent population sample: the Odense schoolchild study. Am J Respir Crit Care Med 1994; 149: 598-603.
11. Charlton I, Antoniou AG, Atkinson J, et al. Asthma at the interface: bridging the gap between general practice and a district general hospital. Arch Dis Child 1994; 70: 313-318.
12. Brand PLP, Kerstjens HAM, Postma DS, Dutch CNSLD Study Group. Long-term clinical trials in obstructive lung disease: principles and practice. Pharmaceut Med 1992; 5: 263-289.
13. Zapletal A, Samanek M, Paul T. Lung function in children and adolescents: methods, reference values. In: Zapletal A, ed. Progress in Respiration Research. 1987; 22: 114-218.
14. Brand PLP, Postma DS, Kerstjens HAM, Koëter GH, Dutch CNSLD Study Group. Relationship of airway hyperresponsiveness to respiratory symptoms and diurnal peak flow variation in obstructive lung disease. Am Rev Respir Dis 1991; 143: 916-921.
15. Ryan G, Latimer KM, Dolovich J, Hargreave FE. Bronchial responsiveness to histamine: relationship to diurnal variation of peak flow rate, improvement after bronchodilator, and airway calibre. Thorax 1982; 37: 423-429.
16. Quackenboss JJ, Lebowitz MD, Krzyzanowski M. The normal range of diurnal changes in peak expiratory flow rates: relationship to symptoms and respiratory disease. Am Rev Respir Dis 1991; 143: 323-330.
17. Clough JB, Holgate ST. Episodes of respiratory morbidity in children with cough and wheeze. Am J Respir Crit Care Med 1994; 150: 48-53.
18. Reddel HK, Salome CM, Peat JK, Woolcock AJ. Which index of peak expiratory flow is most useful in the management of stable asthma? Am J Respir Crit Care Med 1995; 151: 1320-1325.
19. Brand PLP, Kerstjens HAM, Postma DS, et al. Long-term multicentre trial in chronic nonspecific lung disease: methodology and baseline assessment in adult patients. Eur Respir J 1992; 5: 21-31.
20. Waalkens HJ, van Essen-Zandvliet EEM, Hughes MD, et al. Cessation of long-term treatment with inhaled corticosteroid (budesonide) in children with asthma results in deterioration. Am Rev Respir Dis 1993; 148: 1252-1257.
21. Kerstjens HAM, Brand PLP, Hughes MD, et al. A comparison of bronchodilator therapy with or without inhaled corticosteroid therapy for obstructive airways disease. N Engl J Med 1992; 327: 1413-1419.
22. Agertoft L, Pedersen S. Effects of long-term treatment with an inhaled corticosteroid on growth and pulmonary function in asthmatic children. Respir Med 1994; 88: 373-381.
23. Haahtela T, Jarvinen M, Kava T, et al. Effects of reducing or discontinuing inhaled budesonide in patients with mild asthma. N Engl J Med 1994; 331: 700-705.